What are the benefits of open access publishing, and how can we improve equity in academic and medical communications?
To celebrate Open Access Week 2020, Open Pharma teamed up with NetworkPharma and MedComms Networking to host an expert panel discussion on multi-stakeholder perspectives on open access publishing of pharma-sponsored research.
Is it not ironic that the scientific community often fails to recognize the public in publications?
During Open Access Week 2020 and one year after the launch of the Open Pharma position statement on open access, we bring together stakeholders from different backgrounds to share their perspectives on open access publishing of pharma-sponsored research.
One month into my role at Oxford PharmaGenesis has taught me more about scientific and medical publishing than 6 years in the world of academic research. Here, I discuss some of the key issues around academic publishing, and how some researchers in academia could learn from best practices developed to ensure compliance, transparency and integrity in the medical communications industry.
Inspiring STEM Consulting has recently worked with a number of clients to research the open peer review market for scientific journals. Specifically, we have looked at whether open peer review is a sustainable and scalable model and also considered the practical issues.
In a pre-COVID-19 world, this week would have seen evidence-based medicine experts gather in Toronto for EBM Live 2020. However, like many other meetings during the pandemic, it has been postponed. Here, I reflect on last year’s meeting and pharma’s journey in improving the reporting of clinical trials.
The hallmarks of sound science are reproducibility and generalizability that have been subjected to scientific peer review. If any of these characteristics is missing, science is lost. It sounds very simple, but anomalies and deficiencies are everywhere.
This year, the Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) went virtual. With a mix of engaging live and recorded sessions, 15 roundtables and over 45 posters to delve into, we share some of the highlights from the meeting.
Open Pharma Members, Supporters and key Advisers came together to discuss the ways in which the scientific publishing community can make research accessible, discoverable and transparent for patients and the public.